Dr. Collins is an international authority in urology and genomics, having invented the End Sequence Profiling (ESP) technology, which has opened new avenues for personalized cancer treatment.

He has a rich educational and academic background, including a PhD in medical genetics and a bachelor’s degree in biology, and has taught at several renowned universities.

He is currently a professor at UBC and a senior scientist at the Vancouver Prostate Centre, and his research in genomics has driven the development of personalized cancer treatment.